News We’re Watching: HistoSonics Secures $90M VA Deal, CRC Blood Test Deemed Less Cost-Effectiveness, More

 
• By Marion Webb, Elizabeth Orr, Natasha Barrow, and Brian Bossetta
  
"News We're Watching" Feature Image
• Source: Medtech Insight

More from R&D

More from News We're Watching